Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Dyne Therapeutics
Biotech
Dyne's DMD trial back on track after FDA lifts clinical hold
Dyne Therapeutics is back on track to move its first asset into the clinic in the coming weeks after the FDA lifted a clinical hold on the drug.
James Waldron
Jul 5, 2022 10:00am
Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work
Sep 29, 2021 7:00am
Dyne Therapeutics gunning for $100M IPO weeks after a VC raise
Aug 26, 2020 7:55am
Dyne Therapeutics grabs $115M to ramp up muscle disease pipeline
Aug 10, 2020 9:54am
Startup Dyne Therapeutics hires Kaleido exec as new chief
Oct 1, 2019 6:42am